PGGM Investments’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $152M | Sell |
309,197
-37,174
| -11% | -$20.2M | 2.66% | 8 |
|
|
2025
Q4 | $201M | Sell |
346,371
-45,549
| -12% | -$25.8M | 3.18% | 4 |
|
|
2025
Q3 | $190M | Hold |
391,920
| – | – | 3.08% | 6 |
|
|
2025
Q2 | $159M | Buy |
391,920
+202,045
| +106% | +$84.5M | 2.76% | 8 |
|
|
2025
Q1 | $94.5M | Sell |
189,875
-14,447
| -7% | -$7.82M | 1.27% | 21 |
|
|
2024
Q4 | $106M | Buy |
204,322
+532
| +0.3% | +$292K | 1.41% | 23 |
|
|
2024
Q3 | $126M | Buy |
203,790
+2,138
| +1% | +$1.27M | 1.61% | 21 |
|
|
2024
Q2 | $112M | Buy |
201,652
+3,135
| +2% | +$1.8M | 1.6% | 18 |
|
|
2024
Q1 | $115M | Buy |
198,517
+1,585
| +0.8% | +$889K | 1.67% | 14 |
|
|
2023
Q4 | $105M | Sell |
196,932
-3,129
| -2% | -$1.51M | 1.59% | 15 |
|
|
2023
Q3 | $101M | Sell |
200,061
-10,862
| -5% | -$5.79M | 1.75% | 15 |
|
|
2023
Q2 | $110M | Sell |
210,923
-2,616
| -1% | -$1.41M | 1.78% | 16 |
|
|
2023
Q1 | $123M | Buy |
213,539
+385
| +0.2% | +$217K | 2.07% | 11 |
|
|
2022
Q4 | $117M | Sell |
213,154
-3,948
| -2% | -$2.09M | 2.05% | 10 |
|
|
2022
Q3 | $110M | Buy |
+217,102
| New | +$121M | 1.94% | 10 |
|
|
2022
Q1 | $191M | Hold |
286,741
| – | – | 0.95% | 22 |
|
|
2021
Q4 | $191M | Sell |
286,741
-1,407
| -0.5% | -$878K | 0.95% | 22 |
|
|
2021
Q3 | $165M | Sell |
288,148
-51,044
| -15% | -$28M | 0.85% | 26 |
|
|
2021
Q2 | $171M | Sell |
339,192
-21,787
| -6% | -$10.3M | 0.73% | 30 |
|
|
2021
Q1 | $165M | Sell |
360,979
-9,527
| -3% | -$4.55M | 0.71% | 35 |
|
|
2020
Q4 | $173M | Sell |
370,506
-10,129
| -3% | -$4.75M | 0.8% | 34 |
|
|
2020
Q3 | $168M | Sell |
380,635
-14,000
| -4% | -$5.78M | 0.88% | 33 |
|
|
2020
Q2 | $143M | Buy |
394,635
+146,470
| +59% | +$49.1M | 0.83% | 33 |
|
|
2020
Q1 | $70.4M | Buy |
248,165
+53,591
| +28% | +$16.9M | 0.51% | 59 |
|
|
2019
Q4 | $63.2M | Buy |
194,574
+5,300
| +3% | +$1.61M | 0.36% | 67 |
|
|
2019
Q3 | $55.1M | Sell |
189,274
-13,000
| -6% | -$3.72M | 0.26% | 108 |
|
|
2019
Q2 | $59.4M | Buy |
202,274
+14,000
| +7% | +$3.86M | 0.3% | 94 |
|
|
2019
Q1 | $51.5M | Hold |
188,274
| – | – | 0.26% | 102 |
|
|
2018
Q4 | $42.1M | Hold |
188,274
| – | – | 0.24% | 109 |
|
|
2018
Q3 | $46M | Hold |
188,274
| – | – | 0.24% | 115 |
|
|
2018
Q2 | $39M | Hold |
188,274
| – | – | 0.21% | 134 |
|
|
2018
Q1 | $38.9M | Hold |
188,274
| – | – | 0.22% | 132 |
|
|
2017
Q4 | $35.7M | Hold |
188,274
| – | – | 0.2% | 146 |
|
|
2017
Q3 | $35.6M | Sell |
188,274
-14,000
| -7% | -$2.54M | 0.18% | 154 |
|
|
2017
Q2 | $35.3M | Hold |
202,274
| – | – | 0.18% | 153 |
|
|
2017
Q1 | $31.1M | Hold |
202,274
| – | – | 0.16% | 185 |
|
|
2016
Q4 | $28.5M | Hold |
202,274
| – | – | 0.15% | 212 |
|
|
2016
Q3 | $32.2M | Hold |
202,274
| – | – | 0.16% | 181 |
|
|
2016
Q2 | $29.9M | Buy |
202,274
+141,913
| +235% | +$20.9M | 0.15% | 185 |
|
|
2016
Q1 | $8.55M | Buy |
+60,361
| New | +$8.09M | 0.05% | 307 |
|
|
2014
Q2 | – | Sell |
-336,917
| Closed | -$40.5M | – | 386 |
|
|
2014
Q1 | $40.5M | Buy |
336,917
+16,504
| +5% | +$1.96M | 0.21% | 100 |
|
|
2013
Q4 | $35.7M | Sell |
320,413
-5,393
| -2% | -$536K | 0.2% | 158 |
|
|
2013
Q3 | $30M | Sell |
325,806
-529,276
| -62% | -$47.9M | 0.17% | 167 |
|
|
2013
Q2 | $72.4M | Buy |
+855,082
| New | +$71.2M | 0.43% | 61 |
|
Other funds holding TMO
VCM
PGGM Investments's TMO Position: Q1 2026 in Review
PGGM Investments reduced its Thermo Fisher Scientific (TMO) stake by 11% in Q1 2026, selling an estimated $20.2M and leaving 309,197 shares worth $152M. The position accounts for 2.66% of the portfolio, ranked #8.
PGGM Investments first reported a position in TMO in Q2 2013 and has held it in 44 quarters since. The position peaked at $201M in Q4 2025. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- PGGM Investments held 309,197 shares of Thermo Fisher Scientific worth $152M as of Q1 2026.
- PGGM Investments sold 37,174 Thermo Fisher Scientific shares in Q1 2026, an estimated $20.2M.
- Thermo Fisher Scientific made up 2.66% of PGGM Investments's portfolio in Q1 2026, its #8 holding.
- PGGM Investments first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 44 quarters since.
- PGGM Investments's Thermo Fisher Scientific position peaked at $201M in Q4 2025.
- 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on PGGM Investments's 13F filing for Q1 2026, filed 15 May 2026.